Search for:

Search Medicine or Company Name Search Full Document

Advanced Search

BOOTS COMPANY PLC
1 Thane Road West, Beeston, Nottingham, NG2 3AA Telephone: +44 (0)1159 595 306 Fax: +44 (0)1159 592 565 Need to contact this company?

Summary of Product Characteristics last updated on the eMC: 22/03/2002

SPC	Boots Dual Action Athlete's Foot Cream

Table of Contents

1. NAME OF THE MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
3. PHARMACEUTICAL FORM
4. CLINICAL PARTICULARS
4.1 Therapeutic indications
4.2 Posology and method of administration
4.3 Contraindications
4.4 Special warnings and precautions for use
4.5 Interaction with other medicinal products and other forms of interaction
4.6 Pregnancy and lactation
4.7 Effects on ability to drive and use machines
4.8 Undesirable effects
4.9 Overdose
5. PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
5.2 Pharmacokinetic properties
5.3 Preclinical safety data
6. PHARMACEUTICAL PARTICULARS
6.1 List of excipients
6.2 Incompatibilities
6.3 Shelf life
6.4 Special precautions for storage
6.5 Nature and contents of container
6.6 Special precautions for disposal and other handling
7. MARKETING AUTHORISATION HOLDER
8. MARKETING AUTHORISATION NUMBER(S)
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
10. DATE OF REVISION OF THE TEXT

Go to top of the page

1. NAME OF THE MEDICINAL PRODUCT

Boots Dual Action Athlete's Foot Cream

Go to top of the page

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Tolnaftate BP	1.0%w/w
Benzalkonium chloride solution BP	0.2%v/w

Go to top of the page

3. PHARMACEUTICAL FORM

Cream

Go to top of the page

4. CLINICAL PARTICULARS

Go to top of the page

4.1 Therapeutic indications

Boots Dual Action Athlete's Foot Cream is indicated for the treatment and prevention of Athlete's Foot (Tinea Pedis). It is also effective in other conditions, such as Dhobie Itch (Tinea Cruris).

Go to top of the page

4.2 Posology and method of administration

Adults, children and the elderly: The affected area should be treated morning and night. Treatment should continue for at least a week after the infection has cleared.

Go to top of the page

4.3 Contraindications

Hypersensitivity to any of the ingredients.

Go to top of the page

4.4 Special warnings and precautions for use

Keep all medicines out of the reach of children.

For external use only.

If symptoms persist consult your doctor.

Go to top of the page

4.5 Interaction with other medicinal products and other forms of interaction

No clinically significant drug interactions known.

Go to top of the page